These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1190066)

  • 21. Importance of More Potent Antiplatelet Therapy in Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock.
    Effron MB
    Mayo Clin Proc; 2022 Jun; 97(6):1041-1043. PubMed ID: 35662420
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of prenalterol in cardiogenic shock occurring in acute myocardial infarct].
    Coma-Canella I
    Ter Arkh; 1982; 54(11):104-5. PubMed ID: 6130619
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of cardiogenic shock in myocardial infarct].
    Smetnev AS; Petrova LI; Dobrotvorskaia TE
    Ter Arkh; 1973; 45(2):95-101. PubMed ID: 4768363
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inotropic Support During Infarct-related Cardiogenic Shock].
    Janssens U; Riessen R
    Dtsch Med Wochenschr; 2017 Jun; 142(11):811-815. PubMed ID: 28564732
    [No Abstract]   [Full Text] [Related]  

  • 25. Reserpine therapy and shock in myocardial infarction.
    Trappler B; Forman MB; Millar RN; Obel IW
    S Afr Med J; 1977 Oct; 52(19):750. PubMed ID: 601651
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiogenic shock after myocardial infarction].
    Allemann U
    Schweiz Med Wochenschr; 1972 Jul; 102(28):994-7. PubMed ID: 5049605
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of acute myocardial infarct].
    Cyran J
    Internist (Berl); 1980 Nov; 21(11):675-84. PubMed ID: 6778837
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cardiogenic shock caused by right ventricular infarction--new perspective for the use of hypertonic solutions].
    Serrano Júnior CV; Ramires JA
    Arq Bras Cardiol; 1991 Dec; 57(6):433-4. PubMed ID: 1824214
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
    Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
    J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of shock following myocardial infarction.
    Cohn JN
    J Okla State Med Assoc; 1969 Dec; 62(12):564-7. PubMed ID: 5406885
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy.
    Col NF; Gurwitz JH; Alpert JS; Goldberg RJ
    Am J Cardiol; 1994 Jan; 73(2):149-57. PubMed ID: 8296736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Shock caused by myocardial infarction--various problems of etiopathogenesis and treatment].
    Kuch J
    Kardiol Pol; 1985; 28(2):157-64. PubMed ID: 3900516
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolytic therapy in patients where hypotension or cardiogenic shock complicate acute myocardial infarction.
    Prewitt RM
    Can J Cardiol; 1993 Mar; 9(2):155-7. PubMed ID: 8490783
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of "shock" in acute myocardial infarction.
    Shah S
    Indian Heart J; 1973 Apr; 25(2):76-8. PubMed ID: 4726266
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit].
    Amtorp O; Christiansen I; Wennevold A
    Ugeskr Laeger; 1971 May; 133(18):867-70. PubMed ID: 5577747
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute inferior myocardial infarction with right ventricular infarction is more prone to develop cardiogenic shock.
    Bari MA; Roy AK; Islam MZ; Aditya G; Bhuiyan AS
    Mymensingh Med J; 2015 Jan; 24(1):40-3. PubMed ID: 25725666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
    Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
    Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: myocardial injury and death in acute infarction.
    Rajapakse DA; Gunraj DR
    Br Med J; 1975 Apr; 2(5962):86. PubMed ID: 1131560
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism and treatment of myocardial infarction shock.
    Mason DT
    Singapore Med J; 1973 Sep; 14(3):261-3. PubMed ID: 4777875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.